Teva pharmaceutical industries ltd (TEVA)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09Dec'08Sep'08Jun'08Mar'08
Net revenues

17,095

16,887

16,726

16,991

17,355

18,271

19,161

20,249

21,268

21,853

23,479

23,425

22,743

21,903

20,292

19,552

19,480

19,652

19,939

20,174

20,253

20,272

20,534

20,535

20,414

20,314

20,133

20,046

20,116

20,317

20,744

20,116

19,334

18,312

17,054

16,960

16,548

16,121

15,505

14,805

14,405

13,899

12,945

12,237

11,660

11,085

0

0

0

Cost of sales

9,352

9,351

9,176

9,293

9,518

9,975

10,564

10,979

11,176

11,237

11,951

11,746

11,042

10,250

8,976

8,266

8,169

8,296

8,541

8,738

9,058

9,216

9,473

9,653

9,600

9,607

9,535

9,477

9,483

9,665

9,996

9,723

9,398

8,797

7,956

7,641

7,308

7,056

6,805

6,644

6,596

6,532

6,078

5,806

5,493

5,117

0

0

0

Gross profit

7,744

7,537

7,550

7,697

7,837

8,296

8,596

9,269

10,091

10,615

11,528

11,679

11,701

11,653

11,316

11,286

11,311

11,356

11,398

11,436

11,195

11,056

11,061

10,882

10,814

10,707

10,598

10,569

10,633

10,652

10,748

10,393

9,936

9,515

9,098

9,319

9,240

9,065

8,700

8,161

7,809

7,367

6,867

6,431

6,167

5,968

0

0

0

Research and development expenses

970

1,010

1,072

1,143

1,157

1,213

1,264

1,484

1,663

1,778

2,082

2,214

2,120

2,077

1,873

1,571

1,582

1,525

1,458

1,509

1,467

1,488

1,520

1,456

1,451

1,427

1,458

1,434

1,393

1,356

1,285

1,203

1,148

1,095

1,012

1,009

983

951

905

861

813

825

798

797

826

786

0

0

0

Selling and marketing expenses

2,579

2,614

2,706

2,810

2,826

2,916

2,769

2,913

3,175

3,395

3,597

3,694

3,702

3,583

3,647

3,487

3,395

3,478

3,568

3,738

3,799

3,861

3,987

4,008

4,069

4,080

4,004

3,947

3,946

3,879

3,859

3,751

3,574

3,478

3,263

3,208

3,048

2,968

2,899

2,819

2,824

2,676

2,422

2,243

2,094

1,842

0

0

0

General and administrative expenses

1,204

1,192

1,217

1,241

1,261

1,298

1,304

1,367

1,414

1,451

1,566

1,504

1,452

1,390

1,337

1,343

1,357

1,360

1,268

1,245

1,222

1,217

1,213

1,217

1,234

1,239

1,241

1,236

1,233

1,238

1,235

1,055

1,023

932

875

999

904

865

825

801

809

823

787

731

703

669

0

0

0

Intangible assets impairments

1,819

1,639

1,952

2,294

2,254

1,991

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill impairment

-

-

-

-

-

3,027

6,400

0

0

-

-

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets impairments, restructuring and other items

543

423

415

394

487

987

1,461

1,872

2,097

1,836

1,618

658

951

830

629

1,423

996

1,176

1,254

1,034

892

650

824

826

787

788

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Legal settlements and loss contingencies

1,096

1,178

1,202

753

127

-1,208

-1,063

-1,102

-798

500

549

1,102

944

899

774

161

379

631

487

445

87

-111

-52

117

1,526

1,524

889

1,973

593

715

2,056

976

649

471

238

134

415

410

-553

-597

-658

-638

-287

-190

-138

-124

0

0

0

Other income

83

76

-14

7

94

291

1,433

1,402

1,330

1,199

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of research and development in process

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

-

1,402

0

0

0

Operating (loss) income

-386

-443

-3,755

-3,658

-3,028

-1,637

-11,490

-11,128

-16,854

-17,484

-4,604

-4,217

1,884

2,154

3,222

3,467

3,768

3,352

3,363

3,465

3,728

3,951

3,569

3,258

1,747

1,649

1,419

558

2,151

2,205

2,485

3,580

3,170

3,109

3,273

3,426

3,904

3,871

3,509

3,074

2,701

2,405

1,581

1,450

1,386

1,145

0

0

0

Financial expenses, net

-828

-822

-858

-876

-906

-959

-927

-957

-959

-895

-1,481

-1,372

-1,239

-1,330

-623

-1,170

-1,106

-1,000

-1,000

-387

-424

-313

-302

-294

-305

-399

-486

-483

-491

-386

-308

-302

-185

-153

-132

-68

-236

-225

-204

-253

-166

-202

-478

-369

-342

-345

0

0

0

Income (loss) before income taxes

-1,214

-1,265

-4,613

-4,534

-3,934

-2,596

-12,417

-12,085

-17,813

-18,379

-6,085

-5,589

645

824

2,599

2,297

2,662

2,352

2,363

3,078

3,304

3,638

3,267

2,964

1,442

1,250

933

75

1,660

1,819

2,177

3,278

2,985

2,956

3,141

3,358

3,668

3,646

3,305

2,821

2,535

2,203

1,103

1,081

1,044

800

0

0

0

Income taxes (benefit)

-346

-278

-298

-335

-232

-195

-1,527

-1,995

-1,941

-1,933

-405

296

347

521

713

699

758

634

571

538

552

591

519

371

47

-43

-267

-336

-75

-137

-9

81

69

127

56

156

247

283

330

246

226

166

149

147

117

184

0

0

0

Income before minority interest earnings and equity investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-2,668

-1,384

-305

-616

0

0

0

Share in (profits) losses of associated companies, net

-10

-13

-3

-9

-1

-71

-69

-62

-84

-3

-13

-8

21

8

-103

-109

-118

-121

1

0

-6

-5

-23

-25

-28

-40

-44

-45

-54

-46

-51

-60

-58

-61

-49

-32

-31

-24

-29

-31

-42

-33

-22

-20

-1

-1

0

0

0

Net income (loss)

-878

-1,000

-4,318

-4,208

-3,703

-2,472

-10,959

-10,152

-15,956

-16,449

-5,693

-5,893

319

311

1,783

1,489

1,786

1,597

1,793

2,540

2,746

3,042

2,725

2,568

1,367

1,253

1,156

366

1,681

1,910

2,135

3,137

2,858

2,768

3,036

3,170

3,390

3,339

2,946

2,544

2,267

2,004

932

914

926

615

0

0

0

Net income (loss) attributable to non-controlling interests

-54

-2

-324

-320

-328

-322

-160

-156

-166

-184

10

-7

-19

-18

-19

-4

8

9

18

-8

-11

-13

-23

-15

-16

-16

-53

-53

-53

-53

-14

-7

1

9

12

12

11

8

7

6

5

4

5

5

5

6

0

0

0

Net income (loss) attributable to Teva

-825

-999

-3,994

-3,888

-3,375

-2,150

-10,799

-9,996

-15,790

-16,265

-5,703

-5,886

338

329

1,802

1,493

1,778

1,588

1,775

2,548

2,757

3,055

2,748

2,583

1,383

1,269

1,209

419

1,734

1,963

2,149

3,144

2,857

2,759

3,024

3,158

3,379

3,331

2,939

2,538

2,262

2,000

927

909

921

609

0

0

0

Accrued dividends on preferred shares

-

-

-

-

-

249

260

260

260

260

260

259

260

261

211

147

81

15

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) attributable to ordinary shareholders

-825

-999

-4,048

-4,007

-3,559

-2,399

-11,059

-10,256

-16,050

-16,525

-5,963

-6,145

78

68

1,591

1,346

1,697

1,573

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earnings (loss) per share attributable to ordinary shareholders:
Basic

0.06

0.11

-0.29

-0.63

-0.10

-2.88

-0.27

-0.24

1.04

-11.41

0.52

-5.94

0.57

-1.11

0.35

0.21

0.62

0.56

0.12

0.64

0.52

0.80

1.02

0.88

0.88

0.44

0.84

-0.53

0.74

0.37

-0.09

0.99

0.98

0.57

1.03

0.65

0.85

0.86

1.17

0.89

0.80

0.42

0.73

0.61

0.53

-0.89

0.81

0.68

0.18

Diluted

0.06

0.11

-0.29

-0.63

-0.10

-2.87

-0.27

-0.24

1.03

-11.41

0.52

-5.94

0.57

-1.10

0.35

0.20

0.62

0.55

0.12

0.63

0.52

0.80

1.02

0.87

0.87

0.44

0.84

-0.53

0.74

0.38

-0.09

0.99

0.97

0.58

1.03

0.64

0.84

0.85

1.15

0.88

0.79

0.42

0.72

0.58

0.51

-0.85

0.77

0.65

0.18

Weighted average number of shares (in millions):
Basic

1,093

1,090

1,092

1,092

1,090

1,031

1,018

1,018

1,017

1,014

1,017

1,017

1,016

-2,805

979

914

913

869

851

849

851

855

855

852

850

847

845

849

855

868

869

871

880

883

888

892

897

898

899

895

892

887

884

860

857

784

782

778

776

Diluted

1,096

1,090

1,092

1,092

1,090

1,028

1,018

1,018

1,020

1,013

1,017

1,017

1,017

-2,823

984

920

920

876

862

859

859

862

861

857

852

849

846

849

856

868

869

873

882

884

890

896

902

921

921

921

921

880

915

895

894

790

837

836

817